FI890257A - Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI890257A FI890257A FI890257A FI890257A FI890257A FI 890257 A FI890257 A FI 890257A FI 890257 A FI890257 A FI 890257A FI 890257 A FI890257 A FI 890257A FI 890257 A FI890257 A FI 890257A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- pyridine derivatives
- useful pyridine
- pyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3801440A DE3801440A1 (de) | 1988-01-20 | 1988-01-20 | Disubstituierte pyridine |
| DE3801440 | 1988-01-20 | ||
| IT8821587A IT8821587A0 (it) | 1988-07-29 | 1988-07-29 | Piridine disostituite. |
| IT2158788 | 1988-07-29 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI890257A0 FI890257A0 (fi) | 1989-01-18 |
| FI890257A true FI890257A (fi) | 1989-07-21 |
| FI92195B FI92195B (fi) | 1994-06-30 |
| FI92195C FI92195C (fi) | 1994-10-10 |
Family
ID=25864088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI890257A FI92195C (fi) | 1988-01-20 | 1989-01-18 | Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4968689A (fi) |
| EP (1) | EP0325129B1 (fi) |
| JP (1) | JP2712107B2 (fi) |
| KR (1) | KR890011847A (fi) |
| CN (1) | CN1034716A (fi) |
| AT (1) | ATE111081T1 (fi) |
| AU (1) | AU614810B2 (fi) |
| DE (1) | DE58908290D1 (fi) |
| DK (1) | DK23289A (fi) |
| ES (1) | ES2058343T3 (fi) |
| FI (1) | FI92195C (fi) |
| HU (1) | HU208691B (fi) |
| IL (1) | IL88971A (fi) |
| NO (1) | NO890046L (fi) |
| NZ (1) | NZ227636A (fi) |
| PT (1) | PT89478B (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3505382C2 (de) * | 1985-02-16 | 1990-10-04 | Accord-Landmaschinen Heinrich Weiste & Co Gmbh, 4770 Soest | Zweischeibendüngerstreuer |
| NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
| US5506219A (en) * | 1988-08-29 | 1996-04-09 | E. R. Squibb & Sons, Inc. | Pyridine anchors for HMG-CoA reductase inhibitors |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| DE3925636A1 (de) * | 1989-08-03 | 1991-02-07 | Bayer Ag | Imino-substituierte pyridine |
| US5183897A (en) * | 1989-08-03 | 1993-02-02 | Bayer Aktiengesellschaft | Certain intermediate imino-substituted pyridines |
| DE3929507A1 (de) * | 1989-09-06 | 1991-03-07 | Bayer Ag | Substituierte amino-pyridine |
| DE59410255D1 (de) * | 1993-12-10 | 2003-04-17 | Bayer Ag | Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität |
| AR008789A1 (es) * | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
| US6627636B2 (en) | 2000-06-15 | 2003-09-30 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| US6812345B2 (en) | 2000-06-15 | 2004-11-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| US6620821B2 (en) | 2000-06-15 | 2003-09-16 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| DE10135013A1 (de) * | 2001-07-18 | 2003-01-30 | Bayer Ag | Herstellung von Pyridylverbindungen |
| US7659281B2 (en) | 2006-04-25 | 2010-02-09 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3373467D1 (en) * | 1982-06-14 | 1987-10-15 | Takeda Chemical Industries Ltd | Vinyl carboxylic acid derivatives, their production and use |
| US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
| NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
-
1989
- 1989-01-05 NO NO89890046A patent/NO890046L/no unknown
- 1989-01-09 AT AT89100249T patent/ATE111081T1/de active
- 1989-01-09 EP EP89100249A patent/EP0325129B1/de not_active Expired - Lifetime
- 1989-01-09 ES ES89100249T patent/ES2058343T3/es not_active Expired - Lifetime
- 1989-01-09 DE DE58908290T patent/DE58908290D1/de not_active Expired - Fee Related
- 1989-01-17 NZ NZ227636A patent/NZ227636A/en unknown
- 1989-01-17 US US07/298,453 patent/US4968689A/en not_active Expired - Fee Related
- 1989-01-17 IL IL8988971A patent/IL88971A/xx unknown
- 1989-01-18 PT PT89478A patent/PT89478B/pt not_active IP Right Cessation
- 1989-01-18 FI FI890257A patent/FI92195C/fi not_active IP Right Cessation
- 1989-01-19 KR KR1019890000549A patent/KR890011847A/ko not_active Application Discontinuation
- 1989-01-19 DK DK023289A patent/DK23289A/da not_active Application Discontinuation
- 1989-01-19 AU AU28613/89A patent/AU614810B2/en not_active Ceased
- 1989-01-19 JP JP1008769A patent/JP2712107B2/ja not_active Expired - Lifetime
- 1989-01-19 HU HU89213A patent/HU208691B/hu not_active IP Right Cessation
- 1989-01-20 CN CN89100406A patent/CN1034716A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0325129A2 (de) | 1989-07-26 |
| IL88971A0 (en) | 1989-08-15 |
| EP0325129A3 (en) | 1990-12-19 |
| IL88971A (en) | 1993-07-08 |
| AU614810B2 (en) | 1991-09-12 |
| HU208691B (en) | 1993-12-28 |
| ES2058343T3 (es) | 1994-11-01 |
| CN1034716A (zh) | 1989-08-16 |
| HUT50775A (en) | 1990-03-28 |
| FI92195B (fi) | 1994-06-30 |
| PT89478B (pt) | 1993-12-31 |
| EP0325129B1 (de) | 1994-09-07 |
| DE58908290D1 (de) | 1994-10-13 |
| JPH021478A (ja) | 1990-01-05 |
| NO890046D0 (no) | 1989-01-05 |
| ATE111081T1 (de) | 1994-09-15 |
| FI92195C (fi) | 1994-10-10 |
| NO890046L (no) | 1989-07-21 |
| KR890011847A (ko) | 1989-08-22 |
| DK23289D0 (da) | 1989-01-19 |
| FI890257A0 (fi) | 1989-01-18 |
| JP2712107B2 (ja) | 1998-02-10 |
| US4968689A (en) | 1990-11-06 |
| DK23289A (da) | 1989-07-21 |
| NZ227636A (en) | 1990-09-26 |
| AU2861389A (en) | 1989-07-20 |
| PT89478A (pt) | 1989-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI892603A (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi | |
| FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| DK77090A (da) | Immunmodulerende azaspiraner | |
| FI890257A (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi | |
| NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
| FI102177B1 (fi) | Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet | |
| PL301582A1 (en) | Substituted derivatives 4-phenyl-pyridonyl and 4-phenyl-2-alkoxy pyridine, method of obtaining such derivative and therapeutical agents containing them | |
| NL930126I2 (nl) | Dihydropyridine derivaten, werkwijze voor hun bereiding en farmaceutische preparaten die ze bevatten. | |
| FI93444B (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
| FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
| DE59107336D1 (de) | Oligosaccharidderivate und deren Verwendung in Heilmitteln | |
| FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
| NO895195D0 (no) | Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter. | |
| EP0319962A3 (en) | Piperidinyl methanol derivatives for the treatment of anxiety | |
| KR900007816A (ko) | 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도 | |
| CS194774B2 (en) | Process for preparing derivatives of 1,4-dihydropyridine suitable especially as antihypertensive and antianginar medicament | |
| FI890864A0 (fi) | Anvaendning av 1,4-dihydropyridinderivat. | |
| DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
| SE7407296L (fi) | ||
| ES472771A1 (es) | Procedimiento para la obtencion de 2-piridin-1,4-dihidropi- ridinas | |
| NL7613657A (nl) | Werkwijze voor het bereiden van piperidinede- rivaten, werkwijze voor het bereiden van farma- ceutische preparaten met toepassing daarvan als- mede zo gevormde preparaten. | |
| IE890158L (en) | Pyridine derivatives | |
| TH6242A (th) | อนุพันธุ์ของไตรไซคลิคไพริโตน | |
| DK311284D0 (da) | 3-(4'-aminobutylamino)-propylamino-bleomycin-derivater, deres fremstilling og deres anvendelse som laegemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: BAYER AKTIENGESELLSCHAFT |